v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in- Capital
Retained Earnings
Treasury Shares
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024   30,607,039        
Beginning balance at Dec. 31, 2024 $ 290,799 $ 3 $ 362,644 $ 87,656 $ (130,900) $ (28,604)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net unrealized change in investments, net of tax 6,465         6,465
Issued restricted stock (in shares)   386,231        
Stock-based compensation on restricted stock 1,265   1,265      
Net income 30,474     30,474    
Ending balance (in shares) at Mar. 31, 2025   30,993,270        
Ending balance at Mar. 31, 2025 329,003 $ 3 363,909 118,130 (130,900) (22,139)
Beginning balance (in shares) at Dec. 31, 2024   30,607,039        
Beginning balance at Dec. 31, 2024 290,799 $ 3 362,644 87,656 (130,900) (28,604)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 78,498          
Ending balance (in shares) at Jun. 30, 2025   31,017,570        
Ending balance at Jun. 30, 2025 383,302 $ 3 365,559 166,154 (130,900) (17,514)
Beginning balance (in shares) at Dec. 31, 2024   30,607,039        
Beginning balance at Dec. 31, 2024 290,799 $ 3 362,644 87,656 (130,900) (28,604)
Ending balance (in shares) at Dec. 31, 2025   30,833,776        
Ending balance at Dec. 31, 2025 505,251 $ 3 365,736 283,250 (133,183) (10,555)
Beginning balance (in shares) at Mar. 31, 2025   30,993,270        
Beginning balance at Mar. 31, 2025 329,003 $ 3 363,909 118,130 (130,900) (22,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net unrealized change in investments, net of tax 4,625         4,625
Issued restricted stock (in shares)   24,300        
Stock-based compensation on restricted stock 1,650   1,650      
Net income 48,024     48,024    
Ending balance (in shares) at Jun. 30, 2025   31,017,570        
Ending balance at Jun. 30, 2025 383,302 $ 3 365,559 166,154 (130,900) (17,514)
Beginning balance (in shares) at Dec. 31, 2025   30,833,776        
Beginning balance at Dec. 31, 2025 505,251 $ 3 365,736 283,250 (133,183) (10,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net unrealized change in investments, net of tax (3,433)         (3,433)
Issued restricted stock (in shares)   188,225        
Surrendered shares for tax withholding (in shares)   (316,592)        
Surrendered shares for tax withholding (8,909)   (8,909)      
Stock-based compensation on restricted stock 986   986      
Purchase of treasury stock (in shares)   (370,484)        
Purchase of treasury stock (10,006)       (10,006)  
Net income 36,483     36,483    
Ending balance (in shares) at Mar. 31, 2026   30,334,925        
Ending balance at Mar. 31, 2026 520,372 $ 3 357,813 319,733 (143,189) (13,988)
Beginning balance (in shares) at Dec. 31, 2025   30,833,776        
Beginning balance at Dec. 31, 2025 505,251 $ 3 365,736 283,250 (133,183) (10,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 98,194          
Ending balance (in shares) at Jun. 30, 2026   29,732,416        
Ending balance at Jun. 30, 2026 567,728 $ 3 359,501 381,443 (157,773) (15,446)
Beginning balance (in shares) at Mar. 31, 2026   30,334,925        
Beginning balance at Mar. 31, 2026 520,372 $ 3 357,813 319,733 (143,189) (13,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net unrealized change in investments, net of tax (1,458)         (1,458)
Issued restricted stock (in shares)   28,515        
Stock-based compensation on restricted stock 1,688   1,688      
Purchase of treasury stock (in shares)   (631,024)        
Purchase of treasury stock (14,584)       (14,584)  
Net income 61,710     61,710    
Ending balance (in shares) at Jun. 30, 2026   29,732,416        
Ending balance at Jun. 30, 2026 $ 567,728 $ 3 $ 359,501 $ 381,443 $ (157,773) $ (15,446)